Cemtrex CETX Q3 2024 Earnings Miss EPS 018 vs 007 Expected Cantor8 Deepens Africa Mobile Money Push with Yiksi Limited Acquisition Invesco VLT Down 091 How Low Could It Go 20260515 Eric Trumps Family Portfolio Claim Clashes With Presidents 3642Stock Trading Disclosure Australian Developer Scraps Trump Hotel Project Cites Toxic Brand Image ET Alpha Wealth Summit to Explore AI Oil and Geopolitical Shifts as Market Turning Point Approaches Defense Sector in Focus as US Military Jets and Drones Tracked Near Cuba Harikanta Overseas IPO Day 1 Subscription Status GMP Price Band and Other Details Federal Holidays 2025 When Banks Are Closed Including Memorial Day World Bank Data Highlights Automation Risk 69 of Jobs in India Could Be Threatened Nvidia Revenue Surges 85 as AI Boom Continues Shares Dip on Caution US Prioritizes American AI Integration in Asia Following TrumpXi Talks Huawei Unveils New Chip Design Approach Plans Fall Smartphone Chips Amid US Restrictions and Rivalry with Nvidia Apple Oil Futures Maintain Positive Bias as Rally Potential Persists SAH Q1 2026 Earnings EPS Surpasses Estimates by 1487 Signaling Operational Strength TFSL Q1 2026 Earnings EPS Misses Estimates Slightly Amid Steady Operating Performance COYA Q1 2026 Earnings EPS Beat Provides Silver Lining as Revenue Remains Absent Oxford Lane Capital Corp 875 Notes due 2030 OXLCI Q4 2025 Earnings EPS Misses Estimates Amid Stable Distribution Outlook Anika Therapeutics ANIK Q1 2026 Earnings Surprise EPS Beat Amid Revenue Uncertainty Richard Childress Racing Retires No 8 in Kyle Buschs Honor With Son Brexton Poised to Revive It WaFd Inc WAFDP Q1 2026 Earnings EPS Beats Estimates Amid Solid Operational Performance QUBT Quantum Computing tops Q4 2025 earnings estimates shares climb as revenue jumps 828 year over year BSY Bentley posts 11 percent year over year revenue growth shares rise slightly after narrow quarterly earnings beat MCHX Marchex stock gains 266 percent despite weak Q4 2025 earnings and declining year over year revenue Regeneron Pharmaceuticals REGN Dupixent Secures FDA Approval as First Biologic for Pediatric Chronic Spontaneous Urticaria Expanding Blockbuster Drugs Addressable Market APPF AppFolio Q4 2025 results top EPS estimates shares rise on nearly 20 percent year over year revenue growth CME Group Inc CME Core Oil Futures Trading Venue Under Scrutiny Amid Washington Insider Trading Probe Sachem SCCD Stock What Drives Its Price Steady Decline 20260420